TMDI.F Stock Overview
Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Titan Medical Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.042 |
| 52 Week High | CA$0.19 |
| 52 Week Low | CA$0.037 |
| Beta | 1.98 |
| 1 Month Change | -27.48% |
| 3 Month Change | -39.55% |
| 1 Year Change | -76.79% |
| 3 Year Change | -97.43% |
| 5 Year Change | -98.59% |
| Change since IPO | -99.90% |
Recent News & Updates
Recent updates
Titan Medical reports Q2 results
Aug 11Titan Medical granted 180-day extension to regain compliance with Nasdaq's minimum bid price rule
Jun 29Titan Medical: Developing Single-Access Robotic Assisted Surgical Technologies
Dec 05Titan Medical earns milestone payment of $10M under licensing deal with Medtronic; shares rise 10%
May 28Titan Medical announces $15M bought deal offering
Feb 02Titan Medical announces $10M bought deal offering
Jan 05Titan medical provides regulatory update on its Enos Robotic Single Access System
Dec 30Titan Medical in full compliance with Nasdaq listing criteria
Dec 24Shareholder Returns
| TMDI.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -12.2% | -2.9% | -3.2% |
| 1Y | -76.8% | -3.7% | 19.3% |
Return vs Industry: TMDI.F underperformed the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: TMDI.F underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| TMDI.F volatility | |
|---|---|
| TMDI.F Average Weekly Movement | 14.6% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: TMDI.F's share price has been volatile over the past 3 months.
Volatility Over Time: TMDI.F's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 4 | Paul Cataford | www.titanmedicalinc.com |
Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient’s body during surgical procedures. The company is headquartered in Toronto, Canada.
Titan Medical Inc. Fundamentals Summary
| TMDI.F fundamental statistics | |
|---|---|
| Market cap | US$4.99m |
| Earnings (TTM) | US$6.95m |
| Revenue (TTM) | US$17.63m |
0.7x
P/E Ratio0.3x
P/S RatioIs TMDI.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TMDI.F income statement (TTM) | |
|---|---|
| Revenue | US$17.63m |
| Cost of Revenue | US$0 |
| Gross Profit | US$17.63m |
| Other Expenses | US$10.68m |
| Earnings | US$6.95m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.061 |
| Gross Margin | 100.00% |
| Net Profit Margin | 39.43% |
| Debt/Equity Ratio | 0% |
How did TMDI.F perform over the long term?
See historical performance and comparison